Who makes Epidural Ropivacaine, morphine?

Epidural Ropivacaine, morphine is developed by University of Aarhus.

What development phase is Epidural Ropivacaine, morphine in?

Epidural Ropivacaine, morphine is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Epidural Ropivacaine, morphine

University of Aarhus · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Epidural Ropivacaine, morphine
Sponsor	University of Aarhus
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Continuous Wound Catheter Analgesia Associated With Intravenous Morphine PCA After Thoracotomy (PHASE4)
Paravertebral Analgesia Associated With Intravenous Morphine PCA After Thoracotomy (PHASE3)
Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment (NA)
Enhanced Recovery After Urologic Surgery (NA)
The Impact of Intrathecal Morphine Versus Continuous Epidural Analgesia on Return of Bowel Function in Patients Undergoing Laparoscopic Ileal Conduit (NA)
AoA Guided Thoracic Epidural Analgesia for Abdominal Aortic Repair (NA)
Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia (PHASE2)
Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Epidural Ropivacaine, morphine CI brief — competitive landscape report
Epidural Ropivacaine, morphine updates RSS · CI watch RSS
University of Aarhus portfolio CI